Rat Fuca2 ELISA Kit (V2LY-0626-LY330)

Liu, Q., Dong, H. T., Zhao, T., Yao, F., Xu, Y., Chen, B., ... & Xing, P. (2022). Cancer-associated adipocytes release FUCA2 to promote aggressiveness in TNBC. Endocrine-Related Cancer, 29(3), 139-149.

Quirino, M. W. L., de Barros Albuquerque, A. P., de Souza, M. D. F. D., da Silva Filho, A. F., Martins, M. R., da Rocha Pitta, M. G., ... & de Melo, M. J. B. (2022). FUCA2 and TSTA3 expression in gastric cancer: candidate biomarkers of malignant transformation. Folia Histochemica et Cytobiologica, 60(4), 335-343.

Zhong, A., Chen, T., Xing, Y., Pan, X., & Shi, M. (2021). FUCA2 is a prognostic biomarker and correlated with an immunosuppressive microenvironment in pan-cancer. Frontiers in immunology, 12, 758648.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols